In this study, the EVs secreted by probiotics (O.splanchnicus) alleviate the IBD symptoms, intestinal barrier dysfunction, apoptosis, and inflammation induced by DSS through regulating the NLRP3 inflammasome signaling. This evidence concerns the gene NLRP3 and inflammatory bowel disease.